VAUGHAN, Ontario—Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced the U.S. Food and Drug Administration (FDA) has approved Lumify Preservative Free redness reliever eye drops, an over-the-counter preservative-free eye drop with low-dose OTC brimonidine tartrate for the treatment of ocular redness due to minor eye irritations. “Lumify Preservative Free significantly reduces redness within one minute and lasts up to eight hours," said John Ferris, executive vice president, consumer, Bausch + Lomb.

“We expect to make Lumify Preservative Free available for purchase at major retailers in early 2025 in single-use vials—a convenient on-the-go option for consumers who have sensitivities to preservatives.”

Lumify Preservative Free contains a unique formulation and selectively targets redness, similar to Lumify, the company said. In clinical trials, Lumify Preservative Free was shown to have a low incidence of side effects, like rebound redness and loss of efficacy over time, when used as directed.

"Lumify is a proven redness reliever eye drop that I recommend to my patients,” said Melissa Toyos, MD, and partner, Toyos Clinic, Nashville, Tenn. “Now, with Lumify Preservative Free, my patients will have another convenient treatment option.”